Emerging technologies & innovation systems

A disruptive or path-breaking innovation can deliver remarkable advances in healthcare, agriculture, energy, transport and financial services but innovators in these areas are also faced with great uncertainty around the nature of future business models and value chains. Innogen offers new insights and methodological approaches for foresighting future business models and value chains in the context of an innovation ecosystem that can either support or constrain the eventual market availability of the technology. Innogen’s expertise lies in understanding, assessing and supporting this innovation-led growth.

Projects

In Conversation event: Why is drug R&D so much less efficient now than it was in 1950?

16 March 2023

On the 2nd of February, Dr Farah Huzair, Lecturer in Science, Technology and Innovation Studies, at The University of Edinburgh's School of Social and Political Sciences, and Dr Jack Scannell, CEO of Etheros Pharmaceuticals and Innogen Associate, discussed the reasons underlying the marked decline in drug R&D output efficiency since 1950 and ways to improve it.